Acropolis Investment Management, LLC Gilead Sciences, Inc. Transaction History

Acropolis Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 10, 2019	SELL	$60.54 - $79.0 $97,469 - $127,190	-1,610 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$71.28 - $78.92 $49,183 - $54,454	-690 Reduced 30.0%	1,610 $124,000
Q2 2018 Jul 12, 2018	SELL	$64.88 - $75.68 $12,002 - $14,000	-185 Reduced 7.44%	2,300 $163,000
Q1 2018 Apr 04, 2018	SELL	$72.84 - $88.8 $9,469 - $11,544	-130 Reduced 4.97%	2,485 $187,000
Q4 2017 Jan 11, 2018	BUY	$71.15 - $83.52 $18,143 - $21,297	255 Added 10.81%	2,615 $187,000
Q3 2017 Oct 17, 2017	SELL	$72.11 - $85.47 $85,017 - $100,769	-1,179 Reduced 33.31%	2,360 $191,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $255,197 - $302,478	3,539	3,539 $191,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Acropolis Investment Management, LLC with notifications on news.